IMPACT OF MUTATIONS OUTSIDE V3 ON CORECEPTOR TROPISM PHENOTYPICALLY ASSESSED IN SUBTYPE B HIV-1-INFECTED PATIENTS

被引：0
|
作者：
Monno, L. [1 ]
Saracino, A. [2 ]
Scudeller, L. [3 ]
Punzi, G. [1 ]
Lagioia, A. [1 ]
Brindicci, G. [1 ]
Angarano, G. [1 ]
机构：
[1] Univ Bari, Bari, Italy
[2] Univ Foggia, Foggia, Italy
[3] IRCCS Policlin San Matteo, Pavia, Italy
来源：
INFECTION | 2011年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
下载
收藏
页码：S38 / S39
页数：2
相关论文
共 50 条
  • [1] Impact of Mutations Outside the V3 Region on Coreceptor Tropism Phenotypically Assessed in Patients Infected with HIV-1 Subtype B
    Monno, Laura
    Saracino, Annalisa
    Scudeller, Luigia
    Punzi, Grazia
    Brindicci, Gaetano
    Altamura, Maurantonio
    Lagioia, Antonella
    Ladisa, Nicoletta
    Angarano, Gioacchino
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (11) : 5078 - 5084
  • [2] V3 seroreactivity and sequence variation: Tracking the emergence of V3 genotypic variation in HIV-1-infected patients
    Michael, NL
    Davis, KE
    LoomisPrice, LD
    VanCott, TC
    Burke, DS
    Redfield, RR
    Birx, DL
    AIDS, 1996, 10 (02) : 121 - 129
  • [3] Pace of Coreceptor Tropism Switch in HIV-1-Infected Individuals after Recent Infection
    Arif, Muhammad Shoaib
    Hunter, James
    Leda, Ana Rachel
    Lopes Zukurov, Jean Paulo
    Samer, Sadia
    Camargo, Michelle
    Galinskas, Juliana
    Kallas, Esper Georges
    Komninakis, Shirley Vasconcelos
    Janini, Luiz Mario
    Sucupira, Maria Cecilia
    Diaz, Ricardo Sobhie
    JOURNAL OF VIROLOGY, 2017, 91 (19)
  • [4] Reanalysis of Coreceptor Tropism in HIV-1-Infected Adults Using a Phenotypic Assay with Enhanced Sensitivity
    Wilkin, Timothy J.
    Goetz, Mathew Bidwell
    Leduc, Robert
    Skowron, Gail
    Su, Zhaohui
    Chan, Ellen S.
    Heera, Jayyant
    Chapman, Doug
    Spritzler, John
    Reeves, Jacqueline D.
    Gulick, Roy M.
    Coakley, Eoin
    CLINICAL INFECTIOUS DISEASES, 2011, 52 (07) : 925 - 928
  • [5] Performance of commonly used genotypic assays and comparison with phenotypic assays of HIV-1 coreceptor tropism in acutely HIV-1-infected patients
    Ceresola, Elisa Rita
    Nozza, Silvia
    Sampaolo, Michela
    Pignataro, Angela Rosa
    Saita, Diego
    Ferrarese, Roberto
    Ripa, Marco
    Deng, Wenjie
    Mullins, James I.
    Boeri, Enzo
    Tambussi, Giuseppe
    Toniolo, Antonio
    Lazzarin, Adriano
    Clementi, Massimo
    Canducci, Filippo
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (05) : 1391 - 1395
  • [6] Envelope Coreceptor Tropism, Drug Resistance, and Viral Evolution Among Subtype C HIV-1-Infected Individuals Receiving Nonsuppressive Antiretroviral Therapy
    Kassaye, Seble
    Johnston, Elizabeth
    McColgan, Bryan
    Kantor, Raini
    Enah, Lynn Z.
    Katzenstein, David
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 50 (01) : 9 - 18
  • [7] V3 Sequences and Paired HIV Isolates from 52 Non-Subtype B HIV Type 1-Infected Patients
    Monno, Laura
    Brindicci, Gaetano
    Saracino, Annalisa
    Punzi, Grazia
    Cibelli, Donatella
    Lagioia, Antonella
    Angarano, Gioacchino
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2010, 26 (03) : 365 - 372
  • [8] Impact of HIV-1 subtype in selecting mutations associated with response to boosted tipranavir in HIV-1-infected protease inhibitor experienced patients
    Flandre, P.
    Marcelin, A. G.
    Masquelier, B.
    Descamps, D.
    Izopet, J.
    Charpentier, C.
    Aloui, C.
    Peytavin, G.
    Lavignon, M.
    Calvez, V.
    ANTIVIRAL THERAPY, 2007, 12 (05) : S83 - S83
  • [9] Impact of HIV-1 subtype in selecting mutations associated with response to boosted tipranavir in HIV-1-infected protease inhibitor experienced patients
    Flandre, P.
    Marcelin, A. G.
    Masquelier, B.
    Descamps, D.
    Izopet, J.
    Charpentier, C.
    Aloui, C.
    Peytavin, G.
    Lavignon, M.
    Calvez, V.
    ANTIVIRAL THERAPY, 2007, 12 : S83 - S83
  • [10] Evolution of coreceptor tropism and V3 loop resistance mutations in the blood cellular reservoir after introduction of maraviroc
    Morand-Joubert, L.
    Flandre, P.
    Soulie, C.
    Charpentier, C.
    Desbois, D.
    Ruffault, A.
    Marcelin, A. G.
    Masquelier, B.
    Calvez, V.
    ANTIVIRAL THERAPY, 2009, 14 (04) : A150 - A150
12345